Apeloa Pharmaceutical 普洛药业
22 significant filings since 29 May 2026: 8 on buyback, 5 on guarantee or financial assistance and 2 on dividend, and 4 other kinds. The latest, on 24 Sep 2026: 2026年中期分红派息实施公告. 1 unverified report logged, the latest on 22 Jun 2026.
自 29 May 2026 起有 22 份重大公告：buyback 8 份、guarantee or financial assistance 5 份、dividend 2 份，另有 4 类。最新一份（24 Sep 2026）：2026年中期分红派息实施公告。记录了 1 条未经核实的报道，最新一条见于 22 Jun 2026。
Price History 价格走势
5 sessions 个交易日, 18 Sep to 24 Sep 2026 · Live one-minute prices · High 最高 ¥25.66 · Low 最低 ¥23.01 · −0.08% on the previous close of ¥25.32The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 26 Aug 2024 | 国信证券 | 彭思宇,张佳博 | Buy 买入 | ▼ | Outperform 增持 |
| 21 Apr 2021 | 群益证券 | 王睿哲 | Buy 买入 | ▼ | Outperform 增持 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 国信证券 | 彭思宇,陈曦炳,凌珑 | Outperform 增持 | 23 Aug 2026 | 2 | — |
| 开源证券 | 余汝意,阮帅 | Buy 买入 | 21 Aug 2026 | 3 | — |
| 中邮证券 | 盛丽华,辛家齐 | Buy 买入 | 24 Apr 2026 | 1 | — |
| 信达证券 | 唐爱金 | Unrated | 22 Apr 2026 | 1 | — |
| 群益证券 | 王睿哲 | Outperform 增持 | 21 Apr 2026 | 2 | 21.00 |
| 太平洋 | 周豫,乔露阳 | Buy 买入 | 24 Oct 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 2 of 10 reports. 每行为该券商近十二个月的最新研报；10 份中 2 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。